SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
36 hedge funds and large institutions have $29.5M invested in scPharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
38% less capital invested
Capital invested by funds: $47.3M → $29.5M (-$17.8M)
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$75.1K | |
| 2 | +$67K | |
| 3 | +$26.7K | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$24.2K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$7.29K |
Top Sellers
| 1 | -$212K | |
| 2 | -$208K | |
| 3 | -$202K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$170K |
| 5 |
JP Morgan Chase
New York
|
-$78.2K |